Table 5.
Group | Heart | Liver | Spleen | Lung | Kidney | Organs affected | |
β-actin | ED | Down | Up | 2 | |||
LD | Down | Up | 2 | ||||
VEGF | ED | Up | Down | 2 | |||
LD | Down | Down | Up | 3 | |||
art2 | ED | Down | Up | Up | Up | Down | 5 |
LD | Up | Up | 2 | ||||
Oct4 | ED | Up | Up | Down | 3 | ||
LD | Up | Down | 2 | ||||
TERT | ED | Down | 1 | ||||
LD | 0 | ||||||
H19 | ED | Up | Up | 2 | |||
LD | 0 | ||||||
Igf2 | ED | Up | Up | Up | 3 | ||
LD | 0 | ||||||
Abettant genes | ED | 3 | 3 | 3 | 5 | 4 | 18b |
LD | 1 | 2 | 1 | 3 | 2 | 9b |
a Up, denote a significantly higher histone H4 acetylation than normal control. Down, denote a significantly lower histone H4 acetylation than normal control. ED denotes early death group and LD denotes late death group.
b Total